Qingdao-based developer of phage preparations for animal health, aquatic, pet and feed additive markets.
Established in 2017 and based in Qingdao, China, No-Antibiotics provides integrated solutions for phage-resistant bacteria across animal, fruit and vegetable, and human health sectors. It develops phage preparations for bacteria such as Staphylococcus and Salmonella that cause disease in agriculture and animal husbandry. The company has established the largest enterprise-level phage library in China, holds 21 invention patents as of August 2022, and has an R&D team including 26 masters and 7 PhDs. Its stage is listed as Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in